NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Vertex Pharmaceuticals (NQ: VRTX)
163.36 USD  UNCHANGED
Official Closing Price  /  Updated: 8:00 PM EDT, Apr 18, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,122,146
Open 165.00
Bid (Size) 160.16 (100)
Ask (Size) 166.12 (100)
Prev. Close 163.36
Today's Range 162.66 - 166.12
52wk Range 113.66 - 178.25
Shares Outstanding 254,879,018
Dividend Yield N/A
Performance
YTD
+6.83%
+6.83%
1 Month
-4.34%
-4.34%
3 Month
+4.06%
+4.06%
6 Month
+5.56%
+5.56%
1 Year
+42.49%
+42.49%
Top News
More News
Quotidian Technical Highlights on Selected Biotech Stocks -- Vertex Pharma, VIVUS, Voyager Therapeutics, and Zosano Pharma
from PR Newswire
Vertex to Announce First Quarter 2018 Financial Results on April 26
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2018 financial results on Thursday, April 26, 2018 after the financial markets close. The company will host a conference... Read More
from Business Wire News Releases
More News
Read More
Q-State Biosciences and Vertex Pharmaceuticals Enter into Multi-Year Drug Discovery Collaboration
from Business Wire News Releases
Vertex Appoints Kimberly A. White as Senior Vice President and Chief Communications Officer
from Business Wire News Releases
Significant Progress in Non-opioid Therapy Picks up Steam as Market Projected to Reach $22 Billion by 2022
from PR Newswire
BRIEF-Vertex Pharma CEO's FY 2017 Total Compensation $17.3 Mln
category companyNews
from Reuters: Company News
Why A Biopharma Buying Spree May Target AstraZeneca, Bristol
from Investor's Business Daily
IBB, GILD, BIIB, VRTX: ETF Outflow Alert
category ETFs
from ETF Channel
3 Growth Stocks That Could Put Facebook's Returns to Shame
category CTAS , FB , VRTX , and 1 more.
from Motley Fool
We Did The Math MGK Can Go To $129
category ETFs
from ETF Channel
BRIEF-Vertex Pharmaceuticals CEO Leiden's 2017 Compensation Was $17.2 Mln
category companyNews
from Reuters: Company News
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial